Publications by authors named "Xue-Lin Kwang"

Claim this Profile
T
Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors.
Shen Yon Toh, Hui Sun Leong, Fui Teen Chong, Dorival Mendes Rodrigues-Junior, Meng Jie Ren, Xue Lin Kwang

Dev Cell· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioengineered Hydrogels Recapitulate Fibroblast Heterogeneity in Cancer.
Nicholas Ching Wei Ho, Josephine Yu Yan Yap, Zixuan Zhao, Yunyun Wang, Kanishka Fernando, Xue Lin Kwang

Adv Sci (Weinh)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)'.
Joo-Leng Low, Dawn Pingxi Lau, Xiaoqian Zhang, Xue-Lin Kwang, Neha Rohatgi

EBioMedicine· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib.
Aaron C Tan, Tracy J Loh, Xue Lin Kwang, Gek San Tan, Kiat Hon Lim

Lung Cancer (Auckl)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC).
Joo-Leng Low, Dawn Pingxi Lau, Xiaoqian Zhang, Xue-Lin Kwang, Neha Rohatgi

EBioMedicine· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pairing a prognostic target with potential therapeutic strategy for head and neck cancer.
Sze Min Lek, Ke Li, Qiu Xuan Tan, Nicholas B Shannon, Wai Har Ng, Xue Lin Kwang

Oral Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.
Gillianne G Y Lai, Tse Hui Lim, John Lim, Perry J R Liew, Xue Lin Kwang

J Clin Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal single-cell RNA sequencing of patient-derived primary cells reveals drug-induced infidelity in stem cell hierarchy.
Ankur Sharma, Elaine Yiqun Cao, Vibhor Kumar, Xiaoqian Zhang, Hui Sun Leong, Xue Lin Kwang

Nat Commun· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing.
Rahul Nahar, Weiwei Zhai, Tong Zhang, Angela Takano, Alexis J Khng, Xue Lin Kwang

Nat Commun· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma.
Daniel S W Tan, Fui Teen Chong, Hui Sun Leong, Shen Yon Toh, Dawn P Lau, Xue Lin Kwang

Nat Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time.
Shumei Chia, Joo-Leng Low, Xiaoqian Zhang, Xue-Lin Kwang, Fui-Teen Chong

Nat Commun· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis